Zoliflodacin

DRUG3 trials

Sponsors

Drugs for Neglected Diseases, Global Antibiotics Research and Development Partnership

Conditions

GonorrheaTesticular Abnominalies

Phase 1

Study to Investigate Effect of Food and Safety of a New Formulation of Zoliflodacin

CompletedNCT03718806

Drugs for Neglected DiseasesGonorrhea

Start: 2018-10-03End: 2018-11-12Updated: 2018-12-06

Phase 3

Zoliflodacin in Uncomplicated Gonorrhoea

CompletedNCT03959527

Global Antibiotics Research and Development PartnershipGonorrhea

Start: 2019-11-06End: 2023-09-18Updated: 2025-10-08

Phase 4

Study to Evaluate the Effect of a Single Oral Dose of Zoliflodacin 3 g on Testicular Function in Healthy Adult Men

Not yet recruitingNCT07640477

Global Antibiotics Research and Development PartnershipTesticular Abnominalies

Start: 2026-10-01End: 2027-11-01Target: 200Updated: 2026-06-10

Related Papers

Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial.

2025-12-111 citations

Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against Neisseria gonorrhoeae in a gonococcal hollow-fiber infection model

Frontiers in Pharmacology2023-12-079 citations